Replies to post #103257 on Anavex Life Sciences Corp (AVXL)

[jmvho]

Batermere - Our share price/market cap is an interesting topic. Basparks posted recently about how can the $2.41 billion market cap of AXON ( more than 10x our $235 million market cap ) be justified , and frankly I agree with him. If you look at the 52 week data that AXON presented in November compared to the 57 week data AVXL presented in December, there is no comparison. AXON's presentation is extremely light on data ( 2 slides as I recall ) and the end result shows it maybe extends the effect of the Donepezil by a couple of months but then the same downward trajectory on the graph continues. I would encourage you to compare them if you haven't already.

So, I personally think our share price is being artificially suppressed, either by the market manipulators working for the six million shares that are short or by an interested BP player that hopes to acquires us at the lowest price possible.

[apostrophe]

re:"Fair Market Value currently for AVXL? IMHO it's $5.67/share. That's what Wall St thinks ..."

If Wall Street was right all the time, there would be no such thing as undervalued or overvalued stocks. Obviously, that isn't the case.

There is a saying in business that "perception is reality". It isn't the same as "real" reality, but perceptions are the guiding force in human behavior. With stocks, "value" is, functionally, "perceived value". But, peoples' perceptions of things are highly mallable. So, the stock market is a kind of battleground in a constant state of psychological warfare, which is conducted by entities trying to influence sentiments their way, one way or the other, to achieve financial gain.

One can either trust someone else to do their thinking for them, in which case, you have, what may be characterized as "the herd", or the encircling wolves, to choose from, or, maybe try to become savvy, and figure out what metrics to apply for oneself, to determine when "the price is right".

The stock market is all about unreality. Maybe to become savvy one needs to develop skill at being an "unrealist". :)

[Bourbon_on_my_cornflakes]

please dont indulge in fake news "AVXL needs a conventional/typical Phase 3 trial complete with multicenter testing sites, double blind placebo control, a minimum of 300 participants and well done documentation."

Says WHO? The FDA is in communication with AVXL and will tell them what they want. People who are not expert on what the FDA requires as far as I know should not be making such statements.

Whatever the FDA wants, AVXL will do. Missling has done a great job getting us to P3 and he will put the ball in the end zone in the most efficient manner. As we can see with the specs for the Rett trial, Missling will do what is needed in the most efficient and effective manner.